Rfg Advisory, LLC Cytokinetics Inc Transaction History
Rfg Advisory, LLC
- $3.51 Billion
- Q1 2025
A detailed history of Rfg Advisory, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Rfg Advisory, LLC holds 32,005 shares of CYTK stock, worth $1.08 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
32,005Holding current value
$1.08 Million% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$494 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$399 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$335 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$269 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$205 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.17B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...